Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Erwin P. Gabor
Intrathecal Trastuzumab: Immunotherapy Improves the Prognosis of Leptomeningeal Metastases in HER-2+ Breast Cancer Patient
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Complete Response in HER2+ Leptomeningeal Carcinomatosis From Breast Cancer With Intrathecal Trastuzumab
Breast Cancer Research and Treatment
Cancer Research
Oncology
HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Trastuzumab in Combination With Metronomic Cyclophosphamide and Methotrexate in Patients With HER-2 Positive Metastatic Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
FEN1 Knockdown Improves Trastuzumab Sensitivity in Human Epidermal Growth Factor 2‑positive Breast Cancer Cells
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Pcn75 - Budget Impact Model of Subcutaneous Trastuzumab Compared With Intravenous Trastuzumab on the Treatment of Her-2 Positive Breast Cancer in the Brazilian Private Healthcare System
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PTEN Expression as a Predictor for the Response to Trastuzumab-Based Therapy in Her-2 Overexpressing Metastatic Breast Cancer
PLoS ONE
Multidisciplinary
Clinical Experience of Dual Targeted Blockade (Pertuzumab + Trastuzumab + Docetaxel) in Neoadjuvant Therapy of Early HER-2-Positive Breast Cancer
Effective Pharmacotherapy
Reduction in HER-2 Protein Expression in a Breast Tumor HER-2 Positive After Only One Injection of Trastuzumab: A Case Report
Cases Journal
Targeting HER-2 in Gastric Cancer &Ndash; Incorporation of Trastuzumab Into the Treatment of Operable Disease
Gastrointestinal Cancer: Targets and Therapy
